INS and type 1 diabetes mellitus: In a small, randomized placebo-controlled pilot study comprising newly diagnosed children and adolescents (n = 15) with T1D, the authors explored the effect of once-daily pioglitazone on β-cell preservation by adding pioglitazone to insulin.